News
Feed
Events
Feed
News
+ Events
Feed

Therma Bright Inc.

  • ISIN CA4760231064

Aktuelle News

27 April 2018

15:43 Corporate EN

Therma Bright Inc.

Corporate
EN

Therma Bright Announces 1st Tranche Financing for $550,000 Through an Equity Private Placement and Convertible Debenture Offering

19 April 2018

14:00 Corporate EN

Therma Bright Inc.

Corporate
EN

Therma Bright Announces: Further Testing of TherOZap(TM) Technology at Inhibiting Zika and Other Mosquito Borne Diseases, Proposed Financings and Acquisition Update

3 April 2018

15:32 Corporate EN

Therma Bright Inc.

Corporate
EN

Therma Bright to Amend Definitive Agreement to Acquire ClearTouch(R) Nail Phototherapy Device and no!no! skin(R) Phototherapy Acne Device

14 März 2018

13:00 Corporate EN

Therma Bright Inc.

Corporate
EN

Therma Bright Signs Definitive Agreement to Acquire ClearTouch(R) Nail Phototherapy Device and no!no! skin(R) Phototherapy Acne Device

2 März 2018

14:00 Corporate EN

Therma Bright Inc.

Corporate
EN

Therma Bright Finalizes Terms on Acquisition, Adds Advisory Board Member and Grants Options

7 Februar 2018

13:30 Corporate EN

Therma Bright Inc.

Corporate
EN

Jenex Announces Continuation to BC and Name Change to ‘Therma Bright Inc.’

1 Februar 2018

15:00 Corporate EN

Therma Bright Inc.

Corporate
EN

Jenex Announces Non-Binding Letter of Intent with Quinsam Capital Corp. for $250,000 Investment to Develop CBD and THC Related Thermal Therapy Technology for Pain Relief and Other Pain Related Applications

30 Januar 2018

22:41 Corporate EN

Therma Bright Inc.

Corporate
EN

Jenex Completes Due Diligence on Acquisition Targets

17 Januar 2018

14:08 Corporate EN

Therma Bright Inc.

Corporate
EN

The Jenex Corporation Announces Board Change; Appointment of Advisory Board, Debt Settlement and Option Grants

8 Januar 2018

22:57 Corporate EN

Therma Bright Inc.

Corporate
EN

Jenex’s TherOZap(TM) Technology Indicates Effectiveness in Inhibiting Zika Virus After Pre-Clinical Study

12 Dezember 2017

15:29 Corporate EN

Therma Bright Inc.

Corporate
EN

The Jenex Corporation Announces Graduation to the TSX Venture, Update on Chinese Global Financial Forum and Proposed Acquisition

4 Dezember 2017

15:23 Corporate EN

Therma Bright Inc.

Corporate
EN

The Jenex Corporation Announces Completion of Debt Settlement, Files TherOZap(TM) Device Patent and Presents at Chinese Global Financial Forum

23 November 2017

14:46 Corporate EN

Therma Bright Inc.

Corporate
EN

The Jenex Corporation Announces AGM Results and Submits Application to Graduate to TSXV

2 November 2017

13:01 Corporate EN

Therma Bright Inc.

Corporate
EN

The Jenex Corporation Signs Letter of Intent to Acquire Medical Device Assets

12 Oktober 2017

19:12 Corporate EN

Therma Bright Inc.

Corporate
EN

The Jenex Corporation Reports Promising Initial Results on Zika Virus Testing with TherOZap(TM)

19 September 2017

14:02 Corporate EN

Therma Bright Inc.

Corporate
EN

The Jenex Corporation Announces Approvals of Equity Financing & Move to TSX Venture Exchange (TSXV)

14 September 2017

22:30 Corporate EN

Therma Bright Inc.

Corporate
EN

Jenex Reports Expected Date of Test Results for TherOZap(TM) at Inactivating the Zika Virus

17 August 2017

14:57 Corporate EN

Therma Bright Inc.

Corporate
EN

The Jenex Corporation Announces Conditional Acceptance of Reactivation from NEX to TSX Venture Exchange, TherOZap(TM) Testing and ISO 13485:2003 Update

21 Juni 2017

22:26 Corporate EN

Therma Bright Inc.

Corporate
EN

The Jenex Corporation Completes $317,500 Oversubscribed Non-Brokered Private Placement with Insider Participation

23 Mai 2017

13:00 Corporate EN

Therma Bright Inc.

Corporate
EN

Jenex Finalizing Protocol to Test TherOZap(TM) Against the Zika Virus with University Health Network

18 April 2017

15:17 Corporate EN

Therma Bright Inc.

Corporate
EN

Jenex to Test TherOZap(TM) Working Prototype and Topical Cannabidiol Oil Against the Zika and West Nile Viruses

7 April 2017

15:14 Corporate EN

Therma Bright Inc.

Corporate
EN

Jenex Completes Design of TherOZap(TM) Working Prototype and Signs Service Agreement with University Heath Network to initiate testing against the Zika and West Nile Viruses

6 März 2017

14:20 Corporate EN

Therma Bright Inc.

Corporate
EN

Jenex Provides Update on TherOZap(TM) Working Prototype, and InterceptCS

8 Dezember 2016

15:37 Corporate EN

Therma Bright Inc.

Corporate
EN

Jenex to Test Next Generation Technology, TherOZap(TM) Against the Zika Virus and West Nile Virus

Anstehende Events

Keine Events gefunden